We report a high metastatic potential of β-hCG in BRCA1 defective cancers as inhibition of β-hCG can result in 15% and 55% more reduction in migration and invasion respectively in BRCA1 mutant than in wild-type cancer cells. Here, BRCA1 is linked to cancer.